Document Classification

Section Type: RESULTS

Text: Efficacy of the qHPV vaccine against anal intraepithelial neoplasia associated with HPV-6, 11, 16, or 18 was 50. 3 % (95 % confidence interval [CI], 25. 7 to 67. 2) in the intention-to-treat population and 77. 5 % (95 % CI, 39. 6 to 93. 3) in the per-protocol efficacy population ; the corresponding efficacies against anal intraepithelial neoplasia associated with HPV of any type were 25. 7 % (95 % CI, -1. 1 to 45. 6) and 54. 9 % (95 % CI, 8. 4 to 79. 1), respectively.